Vera Therapeutics, Inc. Class A Common Stock

Vera Therapeutics, Inc. Class A Common Stock (VERA) trades at $30.59 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On valuation, VERA trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Oct 6, 2026.